Showing 676-700 of 1,050 results
Open

Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)

National Institutes of HealthCloses in 628 days
View Details
Open

NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

National Institutes of HealthCloses in 627 days
View Details
Open

BRAIN Initiative: Brain Behavior Quantification and Synchronization- Next Generation Sensor Technology Development (U01 Clinical Trial Optional)

National Institutes of HealthCloses in 422 days
View Details
Open

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)

National Institutes of HealthCloses in 549 days
View Details
Open

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)

National Institutes of HealthCloses in 549 days
View Details
Open

NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional)

National Institutes of HealthCloses in 544 days
View Details
Open

Emerging Global Leader Award (K43 Independent Clinical Trial Required)

National Institutes of HealthCloses in 228 days
View Details
Open

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

National Institutes of HealthCloses in 178 days
View Details
Open

Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required)

National Institutes of HealthCloses in 86 days
View Details
Open

Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)

National Institutes of HealthCloses in 228 days
View Details
Open

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)

National Institutes of HealthCloses in 178 days
View Details
Open

Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)

National Institutes of HealthCloses in 263 days
View Details
Open

Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)

National Institutes of HealthCloses in 178 days
View Details
Open

Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UH3 Clinical Trial Required)

National Institutes of HealthCloses in 627 days
View Details
Open

FY 2024 – 2026 Broad Agency Announcement (BAA), Office of Oceanic and Atmospheric Research (OAR)

DOC NOAA - ERA ProductionCloses in 164 days
View Details
Open

Cultural Anthropology Program Senior Research Awards

U.S. National Science FoundationCloses in 120 days
View Details
Open

Occupational Safety and Health Education and Research Centers (T42)

Centers for Disease Control and Prevention - ERACloses in 921 days
View Details
Open

Limited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)

National Institutes of HealthCloses in 628 days
View Details
Open

Research Experiences and/or Mentoring Networks through Research Education to Enhance Clinician-Scientists' Participation in NIDCDs Research (R25 Clinical Trial Not Allowed)

National Institutes of HealthCloses in 528 days
View Details
Open

Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders(U01 Clinical Trial Optional)

National Institutes of HealthCloses in 64 days
View Details
Open

SEEDING CRITICAL ADVANCES FOR LEADING ENERGY TECHNOLOGIES WITH UNTAPPED POTENTIAL (SCALEUP) READY

Advanced Research Projects Agency Energy Closes in 1259 days
View Details
Open

Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional)

National Institutes of HealthCloses in 64 days
View Details
Open

Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

National Institutes of HealthCloses in 486 days
View Details
Open

NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)

National Institutes of HealthCloses in 506 days
View Details
Open

Fundamental Research to Counter Weapons of Mass Destruction

Defense Threat Reduction AgencyCloses in 3086 days
View Details

Stay Updated

Get notified about new opportunities matching your interests.